TIG Advisors LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-98,500
Closed -$5M 50
2019
Q3
$5M Buy
+98,500
New +$4.63M 0.23% 35
2019
Q2
Sell
-68,400
Closed -$3.26M 54
2019
Q1
$3.26M Buy
+68,400
New +$3.41M 0.14% 44

Other funds holding BMY

TIG Advisors LLC's BMY Position: Q2 2021 in Review

TIG Advisors LLC sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 184,622 shares — an estimated $11.7M sold.

TIG Advisors LLC first reported a position in BMY in Q1 2019 and held it in 3 quarters. The position peaked at $32.1M in Q4 2020. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • TIG Advisors LLC reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • TIG Advisors LLC sold 184,622 Bristol-Myers Squibb shares in Q2 2021, an estimated $11.7M.
  • TIG Advisors LLC first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 3 quarters.
  • TIG Advisors LLC's Bristol-Myers Squibb position peaked at $32.1M in Q4 2020.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on TIG Advisors LLC's 13F filing for Q2 2021, filed 16 Aug 2021.